Related Experiment Video

Updated: Jun 18, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Molecular targets in malignant pleural mesothelioma treatment

Giulia Pasello1, Adolfo Favaretto

  • 1U.O. Oncologia Medica, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.

Current Drug Targets
|November 14, 2009
PubMed

Insights

Malignant pleural mesothelioma (MPM) is a challenging cancer due to resistance to traditional therapies. New targeted drugs focusing on angiogenesis and molecular pathways offer promising systemic treatment options for this aggressive tumor.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Medicine

Background:

  • Malignant mesothelioma, particularly malignant pleural mesothelioma (MPM), is an aggressive cancer with increasing incidence linked to asbestos exposure.
  • MPM exhibits resistance to chemotherapy and radiotherapy, necessitating novel treatment strategies.
  • Understanding the molecular pathways, including angiogenesis, is crucial for developing effective systemic therapies.

Purpose of the Study:

  • To review current targeted therapies for malignant pleural mesothelioma.
  • To evaluate future biologic approaches for the systemic management of MPM.
  • To highlight the role of angiogenesis and molecular targets in MPM treatment.

Main Methods:

  • Review of current literature on targeted therapies and biologic agents for MPM.
  • Analysis of molecular pathways involved in MPM, including growth factors and apoptotic defects.
  • Evaluation of clinical trial data for promising agents targeting angiogenesis and molecular pathways.

Main Results:

  • Vascular endothelial growth factor (VEGF), platelet derived growth factor (PDGF), and epidermal growth factor receptor (EGFR) are key molecular targets in MPM.
  • Tyrosine kinase inhibitors (TKIs) and angiogenesis inhibitors show promise in clinical trials.
  • Biologic drugs targeting apoptotic defects are being explored for MPM treatment.

Conclusions:

  • Targeted therapies and biologic agents represent a promising future for MPM systemic management.
  • Further research into molecular pathways and angiogenesis is essential for defining new therapeutic targets.
  • Multimodality treatment combined with novel systemic approaches may improve outcomes for MPM patients.

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...